1.
Cox analysis of some factors affecting distant metastasis of nasopharyngeal carcinoma after treatment
鼻咽癌治疗后远处转移影响因素的Cox分析
2.
The Survival Analysis Based on Cox Regression;
基于Cox Regression的生存分析
3.
Construction of a New Staging System for Hepatocellular Carcinoma: A Study Based on Multivariate Analysis;
多因素Cox回归分析构建肝癌分期系统
4.
The prognosis was analyzed by Cox multivariate model.
Cox回归模型进行多因素预后分析。
5.
The Cox Regression Analysis of Predictive Factors of Hepatorenal Syndrome;
肝肾综合征预后因素的Cox回归分析
6.
Multivariate analysis of prognostic factors of colorectal cancer with COX proportional hazard model;
大肠癌预后的多因素COX模型分析
7.
The Cox Regression Analysis of the Metastatic Spinal Tumors Prognosis Factor;
脊柱转移癌预后因素的Cox回归分析
8.
COX Proportional Hazards Model Analysis of Prognostic Factors Impacting on Survival of Prostate Cancer
影响前列腺癌预后因素的COX模型分析
9.
Multivariate Analysis of Prognostic Factors of Colorectal Cancer after Radical Surgery by Cox Proportional Hazard Model
结直肠癌术后患者Cox模型预后分析
10.
Cox Regression Analysis of Factors Related to Recurrence of Bulky Early Stage Cervical Cancer
巨块型早期宫颈癌复发COX多因素分析
11.
Prognostic analysis of ovarian cancer using the Cox regression model
卵巢癌患者预后因素的Cox回归分析
12.
Cox regression analysis showed STAT5 was an independent prognostic factor.
Cox回归分析显示STAT5是独立的预后影响因子。
13.
Multivariate Analysis of Prognostic Factors of Esophageal Cancer and Gastric Cardia Carcinoma after Radical Surgery by Cox Proportional Hazard Model;
食管及贲门癌根治术后患者Cox模型预后分析
14.
Prognostic Factors for Patients with Astroglioma and Set up COX s Proportional-Hazards Model;
脑星形细胞瘤患者预后多因素COX模型生存分析
15.
The Analysis of the Expression of COX-2 and Bcl-2 in Barrett s Esophagus and Probability of Esophageal Adenocaicinoma Occurrence;
COX-2和Bcl-2在Barrett食管中的表达与癌变风险分析
16.
COX Regression Analysis of Clinical Correlated Risk Factors of Renal Involvement in Henoch-Schonlein Purpura;
过敏性紫癜肾损害相关危险因素的Cox回归分析
17.
The Cox Regression Analysis of Prognostic Factors of 104 Cases of Patients with Gastric Carcinoma after Gastrectomy;
104例胃癌切除术后预后因素的Cox回归分析
18.
Analysis of withdrawal of rofecoxib-cyclooxygenase-2 specific inhibitor;
高选择性COX-2抑制剂罗非昔布撤市分析